Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$14,088,317
+$1,729,231 QoQ
Shares Held
55,986
-1.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#764
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Dec 31, 2021CallValue
$0
CallShares
0
PutValue
$257,260
PutShares
1,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sigma Planning Corp holds $73,658,587 across 13 Drug Manufacturers - General names. ABBV ranks #3 (19.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,696 | $17,626,824 | |
| 2 | JNJ |
Johnson & Johnson
|
62,029 | $15,753,505 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
55,986 | $14,088,317 | |
| 4 | MRK |
Merck & Co., Inc.
|
45,541 | $5,852,018 | |
| 5 | AMGN |
Amgen Inc
|
14,019 | $5,076,560 | |
| 6 | PFE |
Pfizer Inc
|
210,735 | $5,074,498 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
76,251 | $4,393,582 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
13,992 | $1,767,749 |
All Filings in ABBV
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,088,317 | 55,986 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $12,359,086 | 56,826 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $13,550,370 | 59,304 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $13,642,568 | 58,921 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $18,886,835 | 101,750 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $22,239,709 | 106,146 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $19,038,422 | 107,138 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $21,616,555 | 109,462 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $18,944,212 | 110,449 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $22,671,450 | 124,500 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $11,987,704 | 77,355 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $18,954,171 | 127,158 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $12,472,225 | 92,572 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $16,366,820 | 102,697 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $17,182,051 | 106,318 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $14,291,888 | 106,489 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $15,862,321 | 103,567 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $20,335,888 | 125,445 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $17,469,849 | 129,024 | Shares | Sole | 2022-02-02 | |
| 2021-12-31 | $257,260 | 1,900 | Put | Sole | 2022-02-02 | |
| 2021-09-30 | $13,394,541 | 124,173 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $13,884,344 | 123,263 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $12,410,128 | 114,675 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $13,015,510 | 121,470 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $10,328,262 | 117,916 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $10,802,745 | 110,030 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $6,344,798 | 83,276 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||